Comparison of oxidative stress markers in exhaled breath condensate and in serum of patients with tuberculosis and sarcoidosis;Porównanie wybranych wykładników stresu oksydacyjnego w kondensacie powietrza wydechowego oraz w surowicy u chorych na gruźlicȩ i sarkoidozȩ

Polski Merkuriusz Lekarski

Volumn 19, Issue 109, 2005, Pages 37-40

  Kwiatkowska, Sylwia ^a   Łuczyńska, Maria ^a   Grzelewska Rzymowska, Iwona ^a   Nowak, Dariusz ^a   Ziȩba, Marek ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Expired breath condensate; Hydrogen peroxide; Oxidative stress; Reactive oxygen species; Sarcoidosis; Tuberculosis

Indexed keywords

BIOCHEMICAL MARKER; HYDROGEN PEROXIDE; REACTIVE OXYGEN METABOLITE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; EXHALATION; EXHALED BREATH CONDENSATE; FEMALE; GRANULOMATOUS INFLAMMATION; HIGH RISK PATIENT; HUMAN; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; RISK ASSESSMENT; SARCOIDOSIS; TUBERCULOSIS;

ADULT; BIOLOGICAL MARKERS; BREATH TESTS; CASE-CONTROL STUDIES; EXHALATION; FEMALE; HUMANS; HYDROGEN PEROXIDE; LIPID PEROXIDATION; MALE; MIDDLE AGED; OXIDATIVE STRESS; SARCOIDOSIS; TUBERCULOSIS, PULMONARY;

EID: 22244477068     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Antczak A., Nowak D., Shariati B. i wsp.: Increased hydrogen peroxide and thiobarbituric acid-reactive products in expired breath condensate of asthmatic patients. Eur. Respir. J., 1997, 10, 1235-1241.
2. Balcewicz-Sablinska M.K., Keane J., Kornfeld H. i wsp.: Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-alpha. J. Immunol., 1998, 161, 2636-2641.
3. Baughman R.P., Lower E.E.: The effect of corticosteroid and methotrexate therapy on lung lymphocytes and macrophages in sarcoidosis. Am. Rev. Respir. Dis., 1990, 142, 1268-1271.
4. Chadelat K., Baculard A., Grimfeld A. i wsp.: Pulmonary sarcoidosis in children: serial evaluation of bronchoalveolar lavage cells during corticosteroid treatment. Pediatr. Pulmonol., 1993, 16, 41-47.
5. Chan J., Xiang Y., Magliozzo K.S. i wsp.: Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med., 1992, 175, 1111-1122.
6. Dekhuijzen P.N.R., Aben K.K., Dekker I. i wsp.: Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care. Med., 1996, 154, 813-816.
7. Dziedzic B., Mazanowska-Gajdowicz J., Walczewska A. i wsp.: Comparison of cadmium and enzyme-catalyzed nitrate reduction for determination of NO2/NO3 in breath condensate. Clin. Chim. Acta., 2003, 335, 65-74.
8. Edwards K.M., Cynamon H.M., Voladri R.K. i wsp.: Iron-cofactored superoxide dismutase inhibits host responses to Mycobacterium tuberculosis. Am. J. Respir Crit. Care. Med., 2001, 164, 2213-2219.
9. Firmani M.A., Riley L.W.: Mycobacterium tuberculosis CDC1551 is resistant to reactive nitrogen and oxygen intermediates in vitro. Infect Immun., 2002, 70, 3965-3968.
10. Halliwel B., Clement M.V., Long L.H.: Hydrogen peroxide in the human body. FEBS Letters, 2000, 486, 10-13.
11. Janero D.R.: Malondialdehyde and thiobarbituric acid-reactivity as dignostic indices of lipid peroxidative tissue injury. Free Radical Biol. Med., 1990, 9, 515-540.
12. Kasielski M., Nowak D.: Long-term administration of N-acetycysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease. Respir. Med., 2001, 95, 448-456.
13. Kinnula V.L., Everitt J.L., Whorton A.R. i wsp.: Hydrogen peroxide production by alveolar type II cells, alveolar macrophages and endothelial cells. Am. J. Physiol., 1991, 261, L84-L91.
14. Kwiatkowska S., Piasecka G., Zieba M. i wsp.: Increased serum concentrations of conjugated diens and malondialdehyde in patients with pulmonary tuberculosis. Respir. Med., 1999, 93, 272-276.
15. Lopez M., Sly L.M., Luu Y i wsp.: The 19-kDa Mycobacterium tuberculosis protein induces macrophage apoptosis through Toll-like receptor-2. J. Immunol., 2003, 170, 2409-2416.
16. Loukides S., Bouros D., Papatheodorau G. i wsp.: The relationship among hydrogen peroxide in expired breath condensate, airway inflammation, and asthma severity. Chest., 2002, 121, 338-346.
17. Łuczyńska M., Szkudlarek U., Dziankowska-Bartkowiak B. i wsp.: Elevated exhalation of hydrogen peroxide in patients with systemic sclerosis. Eur. J. Clin. Invest., 2003, 33, 274-279.
18. Nowak D., Ziȩba M., Zawiasa D. i wsp.: Changes of serum concentration of lipid peroxidation products in patients with pneumonia. Monaldi Arch. Chest. Dis., 1996, 51, 188-193.
19. 2 and thiobarbituric acid reactive substances (TBARS) by healthy subjects. Free Radic. Biol. Med., 2001, 30, 178-186.
20. Pryor W.A.: Oxyradicals and related species; their formation, lifetimes and reactions. Ann. Rev. Physiol., 1986, 48, 657-667.
21. Psathakis K., Papatheodorau G., Plataki M. i wsp.: 8-isoprostane, a marker of oxidative stress is increased in the expired breath condensate of ptients with pulmonary sarcoidosis. Chest., 2004, 125, 1005-1011.
22. 2 production by macrophages and neutrophils with homovanillic acid and horse-radish peroxidase. J. Immunol. Meth., 1983, 63, 347-357.
23. Szkudlarek U., Luczynska M., Kasielski M. i wsp.: Exhaled hydrogen peroxide correlates with the release of reactive oxygen species by blood phgocytes in healthy subjects. Respir. Med., 2003, 97, 718-725.